Lista de obras - Michael S Anglesio - Dominio Público Uruguay

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

scientific article published on 25 June 2019

A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.

artículo científico publicado en 2013

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

artículo científico publicado en 2014

ARID1A mutations in endometriosis-associated ovarian carcinomas

artículo científico publicado en 2010

Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review

artículo científico

Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species

artículo científico publicado en 2006

Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.

artículo científico publicado en 2009

Benign serous ovarian tumour: a redefining moment?

artículo científico publicado en 2012

Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.

artículo científico publicado en 2013

Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.

artículo científico publicado en 2011

Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?

artículo científico publicado en 2011

Copy number analysis identifies novel interactions between genomic loci in ovarian cancer

artículo científico publicado en 2010

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research.

artículo científico publicado en 2013

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research.

artículo científico publicado en 2013

Cytokine gene expression signature in ovarian clear cell carcinoma.

artículo científico publicado en 2012

Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers

artículo científico publicado en 2011

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney

artículo científico publicado en 2004

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma

artículo científico publicado en 2020

Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition

artículo científico publicado en 2015

Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging

artículo científico publicado en 2017

Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver

artículo científico publicado en 2014

Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes

artículo científico publicado en 2017

Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatments.

artículo científico publicado en 2014

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

artículo científico publicado en 2013

IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer

artículo científico publicado en 2011

Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer

artículo científico publicado en 2018

LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin

artículo científico publicado en 2012

Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma.

artículo científico publicado en 2013

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma

artículo científico publicado en 2018

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.

artículo científico publicado en 2013

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes

artículo científico publicado en 2015

Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.

artículo científico publicado en 2015

Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.

artículo científico publicado en 2008

Oncogenic mutations in histologically normal endometrium: the new normal?

artículo científico publicado en 2019

Pathogenesis of bowel endometriosis

artículo científico publicado en 2020

Profiling the cancer genome.

artículo científico publicado en 2010

Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.

artículo científico publicado en 2015

Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers

artículo científico publicado en 2011

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

artículo científico publicado en 2020

Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas

artículo científico publicado en 2011

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

artículo científico publicado en 2015

The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers

article

The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer.

artículo científico publicado en 2012

The molecular origin and taxonomy of mucinous ovarian carcinoma

scientific article published on 02 September 2019

Type-specific cell line models for type-specific ovarian cancer research

artículo científico publicado en 2013

You won't believe this old test … that does cheap single-cell mutation detection

scientific article published on 01 July 2018

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

artículo científico publicado en 2023

Lista de obras de Michael S Anglesio

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

ARID1A mutations in endometriosis-associated ovarian carcinomas

Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review

Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species

Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.

Benign serous ovarian tumour: a redefining moment?

Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.

Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.

Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?

Copy number analysis identifies novel interactions between genomic loci in ovarian cancer

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research.

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research.

Cytokine gene expression signature in ovarian clear cell carcinoma.

Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma

Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition

Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging

Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver

Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes

Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatments.

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer

Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer

LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin

Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma.

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes

Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.

Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.

Oncogenic mutations in histologically normal endometrium: the new normal?

Pathogenesis of bowel endometriosis

Profiling the cancer genome.

Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.

Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers

The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer.

The molecular origin and taxonomy of mucinous ovarian carcinoma

Type-specific cell line models for type-specific ovarian cancer research

You won't believe this old test … that does cheap single-cell mutation detection

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study